Ragaglitazar: a novel PPARα & PPARγ agonist with potent lipid-lowering and insulin-sensitizing efficacy in animal models

Por Chakrabarti, Ranjan, Vikramadithyan, Reeba K, Misra, Parimal, Hiriyan, Jagadheshan, Raichur, Suryaprakash, Damarla, Ravi K, Gershome, Cynthia, Suresh, Juluri, Rajagopalan, Ramanujam
Publicado em 2003

Decreased Prevalence of Lymphatic Filariasis among Diabetic Subjects Associated with a Diminished Pro-Inflammatory Cytokine Response (CURES 83)

Por Aravindhan, Vivekanandhan, Mohan, Viswanathan, Surendar, Jayagopi, Muralidhara Rao, Maradana, Pavankumar, Nathella, Deepa, Mohan, Rajagopalan, Ramanujam, Kumaraswami, Vasanthapuram, Nutman, Thomas B., Babu, Subash
Publicado em 2010